Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
TRACON Pharmaceuticals revenue
TRACON Pharmaceuticals's revenue is $12.0 million.
What is TRACON Pharmaceuticals's revenue?
- TRACON Pharmaceuticals's revenue growth from 2014 to 2023 is 52.39%.
- TRACON Pharmaceuticals has 36 employees, and the revenue per employee ratio is $334,583.
- TRACON Pharmaceuticals's peak quarterly revenue was $9.0M in 2023(q2).
- TRACON Pharmaceuticals peak revenue was $12.0M in 2023.
- TRACON Pharmaceuticals annual revenue for 2021 was 346.0K, -88.47% growth from 2018.
- TRACON Pharmaceuticals annual revenue for 2023 was 12.0M, 3,381.21% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
TRACON Pharmaceuticals historical revenue
TRACON Pharmaceuticals annual revenue
TRACON Pharmaceuticals annual revenue over time
| Fiscal year / year | TRACON Pharmaceuticals revenue |
|---|---|
| 2014 | $7.9M |
| 2015 | $3.4M |
| 2016 | $3.4M |
| 2017 | $3.0M |
| 2018 | $3.0M |
| 2021 | $346,000 |
| 2023 | $12.0M |
Rate TRACON Pharmaceuticals' financial transparency
TRACON Pharmaceuticals annual growth
TRACON Pharmaceuticals annual growth rate over time
| Year | TRACON Pharmaceuticals growth |
|---|---|
| 2015 | -56%↓ |
| 2016 | 0%↓ |
| 2017 | -13%↓ |
| 2018 | 0%↓ |
| 2021 | -88%↓ |
| 2023 | 3381%↑ |
TRACON Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
TRACON Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $1.0M |
| 2015 | $1.1M | $4.2M | $1.2M | $1.4M |
| 2016 | $1.2M | $807,000 | $815,000 | $616,310 |
| 2017 | $626,000 | $631,000 | $7.5M | - |
| 2018 | $3.0M | - | - | - |
| 2021 | - | $346,000 | - | - |
| 2023 | - | $9.0M | - | $3.0M |
| 2024 | $100,000 | $55,000 | - | - |
TRACON Pharmaceuticals jobs nearby
Do you work at TRACON Pharmaceuticals?
Did TRACON Pharmaceuticals meet its revenue projections?
TRACON Pharmaceuticals financing
TRACON Pharmaceuticals received early financing of $9.5M on 2007-04-27.
| Series | Round size | Date |
|---|---|---|
| Convertible Note | $9.5M | 04/2007 |
| Debt Financing | $1.5M | 10/2010 |
| Series A | $14M | 04/2011 |
| Series B | $27M | 09/2014 |
| Post Ipo Equity | $5M | 09/2016 |
| Post Ipo Equity | $1M | 05/2017 |
| Post Ipo Equity | $5M | 12/2020 |
| Post Ipo Equity | $10M | 07/2021 |
TRACON Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Arcus Ventures | Series A |
| Jafco Co Ltd | Series A |
| Brookline Venture Partners | Series A |
| Nextech Invest | Series A |
| New Enterprise Associates (NEA) | Series B |
| Arcus Ventures | Series B |
| SAHSEN VENTURES LLC | Series B |
| Brookline Venture Partners | Series B |
| Nextech Invest | Series B |
| BioMed Ventures | Series B |
| JOHNSON & JOHNSON INNOVATION | Post Ipo Equity |
TRACON Pharmaceuticals competitors
TRACON Pharmaceuticals's top competitor, Regeneron, earned an annual revenue of $14.2B.
TRACON Pharmaceuticals's smallest competitor is Cyclacel Pharmaceuticals with revenue of $43.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Regeneron | - | $14.2B | 9,123 | - |
| MacroGenics | - | $150.0M | 307 | - |
| Spectrum Pharmaceuticals | - | $10.1M | 235 | - |
| Cyclacel Pharmaceuticals | - | $43,000 | 18 | - |
| Spring Bank Pharmaceuticals | - | $64.9M | 84 | - |
| True REST | - | $1.5M | 63 | - |
| Artisan Healthcare Consulting | - | $5.0M | 36 | - |
TRACON Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of TRACON Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TRACON Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at TRACON Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TRACON Pharmaceuticals. The data presented on this page does not represent the view of TRACON Pharmaceuticals and its employees or that of Zippia.
TRACON Pharmaceuticals may also be known as or be related to TRACON PHARMACEUTICALS INC., TRACON Pharmaceuticals, TRACON Pharmaceuticals Inc, TRACON Pharmaceuticals, Inc, TRACON Pharmaceuticals, Inc., Tracon Pharmaceuticals Inc and Tracon Pharmaceuticals, Inc.